Hologic Holdings Limited

Activities of head offices · Manchester

ActiveUnited KingdomIncorporated 2018Private Limited Company

Financial position

Accounts to 2025-09-30 · USD · Company accounts

Net assets

USD 1,259,011,623

Cash

—

Turnover

—

Profit / loss

−USD 61,465,043

Current assets

—

Creditors < 1 year

USD 1,029,753,426

Equity

USD 1,259,011,623

Average employees

Not available

USD · company

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

2 periods

Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts

What the accounts for 2025-09-30 say about themselves, read by AI from the scanned filing.

Principal activity: The principal activity of the Company during the period was that of an investment holding company, undertaking intra-group financing and capital management activities within the Hologic Group.
What it does: investment holding · intra-group financing · capital management (AI keywords)
The year: During the year, the Company was involved in a number of intra-group reorganisation and financing transactions undertaken by the wider Hologic group. The loss for the period primarily reflects the impairment of the Company's investment in Hologic IP Limited of $84.3m.
Auditor: Ernst & Young LLP · senior statutory auditor Elizabeth Jones
Audit opinion: Clean (unmodified)
Immediate parent: Hologic GGO 4 Ltd · United Kingdom
Ultimate parent: Hologic, Inc. · United States of America
Ultimate controlling party: entities affiliated with Blackstone and TPG, together with minority investments from Abu Dhabi Investment Authority and GIC (Singapore)
Accounts: Full accounts · FRS 102
Approved: 2026-07-29, signed by Mr A J Broom

Borrowings (3)

Unsecured loan notes due from Hologic GGO4 Limited · $775.0 million · 5% per annum · repayable in 2033
Cash pooling balance · from group undertakings · $2,472 · SOFR+275bps · repayable on demand
Amounts owed to group undertakings · from group undertakings · 1,029,753,426 · interest free · repayable on demand · secured on unsecured

Directors' report (5)

Share classes (1)

Principal risks (4)

Events after the year end (3)

Subsequent to the balance sheet date, the Hologic group was acquired by a consortium of private equity investors. This represents a non-adjusting event after the reporting period.
After the balance sheet date the Company received a dividend of $49,400,000 from Hologic IP Limited. The Company then distributed a dividend of $49,400,000 to Hologic GGO 4 Limited.
Subsequent to the balance sheet date, the Company undertook a reduction of capital in accordance with sections 642 to 644 of the Companies Act 2006, involving cancellation of $1,285,062,367 standing to the credit of the Company's share premium account.

Registered charges, lenders and security interests.

0 outstanding charges

No charges available in our records.